Wenlin Xu

3.8k total citations
101 papers, 2.9k citations indexed

About

Wenlin Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wenlin Xu has authored 101 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 33 papers in Cancer Research and 19 papers in Oncology. Recurrent topics in Wenlin Xu's work include MicroRNA in disease regulation (18 papers), Cancer-related molecular mechanisms research (12 papers) and RNA modifications and cancer (11 papers). Wenlin Xu is often cited by papers focused on MicroRNA in disease regulation (18 papers), Cancer-related molecular mechanisms research (12 papers) and RNA modifications and cancer (11 papers). Wenlin Xu collaborates with scholars based in China, United States and Germany. Wenlin Xu's co-authors include Xiaolan Zhu, Huiling Shen, Yuefeng Li, Yueqin Liu, Lulu Hui, Qi Chen, Lulu Long, Xinming Yin, Qiaoyun Chen and Yue Fang and has published in prestigious journals such as Blood, PLoS ONE and Oncogene.

In The Last Decade

Wenlin Xu

97 papers receiving 2.9k citations

Peers

Countries citing papers authored by Wenlin Xu

Since Specialization

Citations

This map shows the geographic impact of Wenlin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenlin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenlin Xu more than expected).

Fields of papers citing papers by Wenlin Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenlin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenlin Xu. The network helps show where Wenlin Xu may publish in the future.

Co-authorship network of co-authors of Wenlin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenlin Xu. A scholar is included among the top collaborators of Wenlin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenlin Xu. Wenlin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Global burden of cardiovascular disease attributable to metabolic risk factors, 1990–2019: an analysis of observational data from a 2019 Global Burden of Disease study 2023 ·BMJ Open ·Shuyi Wu, Wenlin Xu, (unknown), Meina Lv, Shaojun Jiang, Jinhua Zhang	24
2	A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance 2023 ·Journal of Ovarian Research ·Lu Chen, Wujiang Gao, (unknown), Chunli Sha, Taoqiong Li, Qi Chen, Hong Wei, (unknown), (unknown), Mengxue Zhang, (unknown), Wenlin Xu, Yuefeng Li, Lulu Long, Xiaolan Zhu	12
3	Uniparental disomy: expanding the clinical and molecular phenotypes of whole chromosomes 2023 ·Frontiers in Genetics ·Qi Chen, Yunpeng Chen, (unknown), (unknown), Xiaoguang Li, Xiaolan Zhu, Yan Yang, Wenlin Xu	0
4	An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire 2023 ·Frontiers in Pharmacology ·(unknown), Wenlin Xu, Shuyi Wu, Lien Desteghe, (unknown), Jinhua Zhang	1
5	SMRT and Illumina sequencing provide insights into mechanisms of lignin and terpenoids biosynthesis in Pinus massoniana Lamb 2023 ·International Journal of Biological Macromolecules ·Kang Xu, (unknown), Wenlin Xu, (unknown), (unknown), Zhangqi Yang, Meng Xu	6
6	Off-label dose direct oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation: A new evidence of Asian dose 2022 ·International Journal of Cardiology ·Wenlin Xu, Meina Lv, Tingting Wu, (unknown), Wang Zhang, Jun Su, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yuxin Liu, Min Zhang, Xiumei Liu, Zhu Zhu, Jinhua Zhang	5
7	Impact of Acupuncture on Sleep and Comorbid Symptoms for Chronic Insomnia: A Randomized Clinical Trial 2021 ·Nature and Science of Sleep ·(unknown), Wenlin Xu, Guanwu Li, (unknown), Jinjin Li, (unknown), (unknown), (unknown), Yun-Fei Chen	16
8	Exosomal Non-coding RNAs-Mediated Crosstalk in the Tumor Microenvironment 2021 ·Frontiers in Cell and Developmental Biology ·Qi Chen, Yuefeng Li, Yueqin Liu, Wenlin Xu, Xiaolan Zhu	45
9	The role of differential expressed long non-coding RNA in breast cancer 2019 ·Zhonghua shiyan waike zazhi ·Qi Chen, Yueqin Liu, Hui Yang, (unknown), Wenlin Xu	0
10	Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype 2019 ·Journal of Experimental & Clinical Cancer Research ·Xiaolan Zhu, Huiling Shen, Xinming Yin, Meiling Yang, Hong Wei, Qi Chen, Fan Feng, Yueqin Liu, Wenlin Xu, Yuefeng Li	311
11	Serum Exosomal miR-223 Serves as a Potential Diagnostic and Prognostic Biomarker for Dementia 2018 ·Neuroscience ·Hong Wei, Yuhao Xu, Wenlin Xu, Qianwen Zhou, Qi Chen, Meiling Yang, (unknown), Yueqin Liu, Xiaolan Zhu, (unknown), Yuefeng Li	76
12	Downregulation of hypermethylated in cancer-1 by miR-4532 promotes adriamycin resistance in breast cancer cells 2018 ·Cancer Cell International ·Fan Feng, Xiaolan Zhu, Chunyan Wang, Liang Chen, (unknown), Yueqin Liu, Qi Chen, Wenlin Xu	14
13	Vascular endothelial growth factor induces multidrug resistance-associated protein 1 overexpression through phosphatidylinositol-3-kinase /protein kinase B signaling pathway and transcription factor specificity protein 1 in BGC823 cell line 2013 ·Acta Biochimica et Biophysica Sinica ·Juan Li, Xiaojun Wu, (unknown), Jing Yang, (unknown), Qiaoyun Chen, Wenlin Xu	11
14	Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis 2013 ·Acta Biochimica et Biophysica Sinica ·Shiguo Liu, Yue Fang, Huiling Shen, Wenlin Xu, Hao Li	64
15	[VEGF shRNA enhances the sensitivity of multidrug-resistant leukemia cells to anticancer agent]. 2011 ·PubMed ·Huiling Shen, Lili Fang, (unknown), Xinjian Fang, Qiaoyun Chen, Juan Li, Wenlin Xu	2
16	Upregulation of mdr1 gene is related to activation of the MAPK/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma 2011 ·Experimental Hematology ·Huiling Shen, Wenlin Xu, Wenjuan Luo, Leilei Zhou, Yong Wei, Fang Chen, Chaoyang Wu, Qiaoyun Chen, Xiao Han	66
17	Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells 2006 ·Leukemia Research ·Huiling Shen, Wenlin Xu, Zhaoyang Wu, (unknown), (unknown), Huarong Tang	21
18	The improvement of some methods involved in yeast two-hybrid experiments 2003 ·Letters in Biotechnology ·Wenlin Xu	1
19	Separation and Purification of Stigmasterol and β-Sitosterol from Phytosterol by the Crystallization Method 2003 ·Guocheng gongcheng xuebao ·Wenlin Xu	1
20	Purification and Recovery Processes of Phytosterols from Deodorizer Distillates 2002 ·Guocheng gongcheng xuebao ·Wenlin Xu	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact